Navigation Links
Hormone Therapy applicable for Prostate Cancer

Researchers made a new study which suggests hormone suppression therapy could increase substantially an advanced prostate cancer patient's chances of living free of the disease.Michel Bolla, a professor at Grenoble University Hospital, examined the potential benefits of suppressing the male hormone androgen, similar to the more commonly known male hormone testosterone, among 400 patients in advanced stages// of their prostate cancer, meaning their chances of survival were deteriorating. The international study involved patients throughout Europe as well as in Canada and Israel.

In the study, the men were randomly assigned to receive either radiation therapy alone or androgen suppression given during and after radiotherapy for three years. The average follow-up period was five and a half years.

Study results revealed almost three-quarters of the men who received the combination therapy, or 70 percent, had an increased five-year, disease-free survival rate compared to only 30 percent of patients who received only radiotherapy. Overall, survival rates were 80 percent within the hormone-suppression group and 62 percent for the radiotherapy group.

Bolla felt that at the present time a long-term hormone therapy 2 or 3 years compared to short-term resulted in statistically significant improvements in overall survival, as shown by this trial. The long-term survival rate for men with aggressive prostate cancer is poor, so additional therapies are needed to improve their chances. He added the findings also indicate hormone suppression with radiotherapy or external irradiation could trigger apoptosis -- the cancer cells destroying themselves.

However, there were side effects, Bolla said, including hot flashes, loss of libido and impotency. Kenneth Koeneman, urology professor at University of Texas Southwestern Medical Center at Dallas, said the side effects go beyond sexual dysfunction. "It's systemic castration," Koeneman told UPI
'"/>




Page: 1 2

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. Hormone replacement Therapy a headache
3. Ovarian cancer in relationship with Hormone therapy
4. Hormone contraceptives lead to bone problems
5. Hormone treatment helps obese people slim down
6. Hormone Deficiency Results In Miscarriage
7. Hormones Linked To Migraines
8. Hormone replacement therapy helps women
9. Decrease of Hunger Hormone after Obesity Surgery
10. Possible benefits of Hormone Replacement Therapy
11. Hormone replacement therapy improves sexual function
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Hormone Therapy applicable for Prostate Cancer

(Date:9/1/2015)... ... September 01, 2015 , ... ... has established the MAP Recovery Network, the Premier Outcomes-Driven Provider Network. It ... rapidly-growing alliance is dedicated to the provision of quality addiction treatment and ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Anthony J. ... the Super Lawyers 2015 for his third consecutive year in a row. Through ... accomplishments of helping people. , Born in Niagara Falls, New York, Tantillo is a ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for the ... understand the scope of their EHS regulatory obligations and rapidly collect, share, archive, ...
(Date:8/31/2015)... West Orange, NJ (PRWEB) , ... September 01, ... ... in the spine to eliminate chronic back pain – once required a long, ... with a shorter hospital stay, less pain, less blood loss and minimal muscle ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... at Western University of Health Sciences to learn more about its integrated approach ... of Dental Sciences and Institute of Cellular Medicine at Newcastle University, and Susan ...
Breaking Medicine News(10 mins):Health News:MAP Health Management Launches the MAP Recovery Network 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 2Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 3Health News:Specialty Technical Publishers (STP) and Specialty Technical Consultants(STC) Publish Environmental, Health & Safety (EHS) Audit Protocol for the European Union 4Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 2Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 3Health News:Minimally Invasive Spinal Fusions Squash Back Pain without Arduous Recovery 4Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4
... (HealthDay News) -- For newly diagnosed cancer patients, appointments with ... those with private health insurance, according to U.S. researchers. ... assistants posing as new cancer patients were unable to obtain ... The findings, from a team at the Perelman School of ...
... data presented at The American Society of Clinical Oncology ... tumor vaccine HSPPC-96 for treating recurrent gliobastoma (GBM) has ... to three times more than the current median survival ... Hospitals Case Medical Center, University of California, San Francisco ...
... epidemic, a once-rare form of cancer known as Kaposi,s sarcoma ... was best illustrated by Tom Hanks, who portrayed a gay ... co-workers in the 1993 movie "Philadelphia." A few years ... searching for a postdoctoral position. He found one, in Philadelphia, ...
... , THURSDAY, June 2 (HealthDay News) -- They are ... new research reveals that used faceshields are more likely to ... equipment managers, conducted by Ohio State University, also found that ... replacement policy in place for used or damaged shields. ...
... , THURSDAY, June 2 (HealthDay News) -- Noisy operating rooms ... infections, new study findings suggest. In the report, ... of Surgery , the Swiss researchers also said these surgical ... hospital stays. "SSIs lead to patients spending up to ...
... than 70 with glioblastoma, the most common and aggressive ... for those living in poorer areas and older than ... presented at the American Society of Clinical Oncology annual ... on Saturday, June 4. ( ABSTRACT #6089 ). ...
Cached Medicine News:Health News:U.S. Cancer Patients Face Barriers to Care, Study Finds 2Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 2Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 3Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 4Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 5Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 6Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 7Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 8Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 9Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 10Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 11Health News:Study finds vaccine extends recurrent GBM survival rates by 2 to 3 times 12Health News:FSU scientist leads research on AIDS-related cancer 2Health News:FSU scientist leads research on AIDS-related cancer 3Health News:Used Football Faceshields May Break on Impact 2Health News:Noisy ORs Linked to Raised Risk of Surgical Site Infection 2Health News:ASCO: Glioblastoma in the 21st century: Wealthier patients living longer than poorer patients 2
(Date:8/31/2015)... 2015 Regen BioPharma, Inc. (OTCBB: RGBP) ... novel means of delivering its patented (US Patent ... tumors utilizing a clinically approved formulation as delivery ... with gene silencing therapeutics in which the gene ... whole body.  By utilizing a local delivery system, ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
(Date:8/31/2015)...  Qualcomm Incorporated (NASDAQ: QCOM ) today ... is collaborating with Davita Healthcare Partners and ... by Qualcomm Life,s 2net™ Device Connectivity Platform and ... informed interventions and better management of at-risk populations. ... Connect 2015 ecosystem conference taking place ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 2Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 3Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 4Qualcomm Life Announces New Connected Health Collaborations at Connect 2015 5
... 7, 2011  Tethys Bioscience has entered into an agreement ... employers measurably flatten the trajectory of their healthcare trends ... their employee populations. The agreement allows ACAP Health to ... as a component of its disease intervention programs. The ...
... 2011 Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE ... and develops new uses for previously approved drugs and ... of the granting of a European patent with broad ... diketopiperazine which is the active ingredient of Ampion™.  The ...
Cached Medicine Technology:Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 2Tethys Bioscience and ACAP Health Consulting Partner to Help Employers Prevent Diabetes 3Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™ 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: